Peter Lynch is probably the greatest mutual fund manager of all time. Here's what he had to say about successful investing...

Instead of thinking about how many times you were right with your stock picks, it's time to start thinking about what really matters: how much money you're making.

New technology is giving doctors is the ability to treat patients with drugs tailored at the molecular level. The implications of this are huge -- here's how I'm planning to invest...

A $74 billion deal will create a biotech powerhouse. But is this a good deal? And is it worth owning today?

It's only been a little over three months since marijuana became legal in Canada, but my top pick is already taking off...

I don't know whether we're out of the woods just yet... but between a couple of bullish indicators, and my system signaling four new buys last week, I'd say the outlook is positive. 

Let's take a look at some of the companies that went public last year -- and see if our next big winning pick is in the group...

We find ourselves on the cusp of a shift in medicine -- one that could not only lead to longer, healthier lives, but also make early investors a fortune...

It looks like Big Pharma is on a buyout spree again. Here's my take on a few promising biotech stocks that could be the next major targets...

I took a close look at the retail sector and identified five names with major upside potential...